Table of Content

1 INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET INSIGHTS
4.1 Market Overview
4.2 Industry Attractiveness - Porter’s Five Forces Analysis
4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Consumers
4.2.3 Threat of New Entrants
4.2.4 Threat of Substitute Products
4.2.5 Intensity of Competitive Rivalry
4.3 Industry Stakeholder Analysis
4.4 Impact of COVID-19 on the Market


5 MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Growing Instances of Convergence Between IT & Healthcare Players Driving Innovations
5.1.2 Expanding Application Base and Growing Emphasis on the Adoption of Digital Transformation Practices to Realize Cost Savings
5.1.3 Increased Emphasis on Ensuring Patient Well-being and Relative Shortage of Physicians in Major Countries to Drive Adoption
5.2 Market Challenges
5.2.1 Initial Implementation and Perception Concerns
5.3 Market Opportunities
5.4 Major Partnerships and Collaborations
5.5 Key Technical and Stakeholder-related Considerations for the Implementation of AI in Medicine


6 TECHNOLOGY SNAPSHOT
6.1 Evolution of AI in the Field of Medicine
6.2 Key Innovations and Advancements
6.2.1 Discovery of Drug Interventions & Candidates
6.2.2 Clinical Trail Facilitation
6.2.3 Identification of Bio-markers
6.2.4 Advancements in Gene Editing
6.3 Major Areas of Research
6.3.1 Cardiology
6.3.2 Pulmonary Medicine
6.3.3 Nephrology
6.3.4 Neurology


7 MARKET SEGMENTATION
7.1 By Application Type
7.1.1 Medical Administration and Support
7.1.2 Patient Management
7.1.3 Research and Development
7.1.4 Other Applications
7.2 By Type
7.2.1 Hardware
7.2.2 Software
7.2.3 Services
7.3 By Geography
7.3.1 North America
7.3.1.1 United States
7.3.1.2 Canada
7.3.2 Europe
7.3.2.1 United Kingdom
7.3.2.2 Germany
7.3.2.3 France
7.3.2.4 The Nordics
7.3.2.5 Rest of Europe
7.3.3 Asia-Pacific
7.3.3.1 China
7.3.3.2 India
7.3.3.3 South Korea
7.3.3.4 Singapore
7.3.3.5 Rest of Asia-Pacific
7.3.4 Latin America
7.3.5 Middle East


8 COMPETITIVE LANDSCAPE
8.1 Company Profiles
8.1.1 Atomwise Inc.
8.1.2 Novo Nordisk A/S
8.1.3 Nano-X Imaging Ltd
8.1.4 Modernizing Medicine Inc.
8.1.5 Berg LLC
8.1.6 Medasense Biometrics Limited
8.1.7 Sense.ly Corporation.
8.1.8 AiCure LLC
8.1.9 Cyrcadia Health


9 INVESTMENT ANALYSIS


10 FUTURE OF THE MARKET